Drug Profile

Diclofenac/menthol

Alternative Names: Diclofenac-menthol; Menthol/diclofenac; MFC 51123

Latest Information Update: 02 Jul 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator GlaxoSmithKline
Developer GSK
Class Cyclohexanols; Monoterpenes; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
Mechanism of Action Cyclooxygenase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

11 Apr 2017 Discontinued - Phase-I for Pain (In volunteers) in USA (Topical), because not listed on GSK pipeline, April 2017
11 Apr 2017 Discontinued - Phase-III for Pain in Germany (Topical), because not listed on GSK pipeline, April 2017
01 Mar 2015 GlaxoSmithKline completes a phase III trial in Pain in Germany (NCT02100670)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com